Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL
about
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL
description
im Januar 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 December 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2019
@uk
name
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@en
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@nl
type
label
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@en
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@nl
prefLabel
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@en
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@nl
P2093
P50
P1433
P1476
Tenofovir vs lamivudine for th ...... vation in advanced-stage DLBCL
@en
P2093
Antonio Giordano
Chiara Mortaruolo
Claudia Giordano
Claudia Salvatore
Fabio Trastulli
Fabrizio Pane
Irene Zacheo
Marco Picardi
Maria Di Perna
Mariano Lucignano
P304
P356
10.1182/BLOOD-2018-10-878892
P407
P50
P577
2018-12-07T00:00:00Z